-
Mashup Score: 1COVID-19 Guideline, Part 1: Treatment and Management - 1 year(s) ago
IDSA has developed living, frequently updated evidence-based guidelines to support patients, clinicians and other health-care professionals in their decisions about treatment and management of patients with COVID-19 infection. Summarized here are the recommendations with comments related to the clinical practice guideline for the treatment and management of COVID-19.
Source: www.idsociety.orgCategories: Infectious Disease, Latest HeadlinesTweet
-
Mashup Score: 0Study provides roadmap for using convalescent plasma as an effective COVID-19 treatment - 1 year(s) ago
A new analysis shows how convalescent plasma can be used to prevent hospitalizations and ultimately save lives, both for COVID-19 and for the next viral pandemic that inevitably arrives.
Source: Brown UniversityCategories: Healthcare Professionals, Latest HeadlinesTweet-
Study provides roadmap for using #convalescentplasma as an effective #COVIDtreatment | Adam C Levine, MD, et al. @BrownUniversity @BrownMedicine https://t.co/TtyAARiWmt
-
-
Mashup Score: 3Efficacy and harms of convalescent plasma for treatment of hospitalized COVID-19 patients: a systematic review and meta-analysis - 2 year(s) ago
Introduction: We systematically reviewed benefits and harms of convalescent plasma (CP) in hospitalized COVID-19 patients. Material and methods: Randomized controlled trials (RCTs) and observational studies assessing CP effects on hospitalized, adult COVID-19 patients were searched until…
Source: www.archivesofmedicalscience.comCategories: Cardiologists, Latest HeadlinesTweet-
Efficacy and harms of #convalescentPlasma for treatment of hospitalized #COVID19 : a #MA https://t.co/mWEuy2V0q3
-
-
Mashup Score: 1
The New England Journal of Medicine (NEJM) today published final results of a nationwide multicenter study led by researchers at Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of Public Health that show plasma from patients who have recovered from COVID-19 and whose blood contains antibodies against SARS-CoV-2, the causative virus, is an effective and safe option as an early…
Source: medicalxpress.comCategories: General Medicine News, Latest HeadlinesTweet-
Study finds #convalescentplasma can be effective early COVID-19 therapy @nejm https://t.co/jrYf2y6KKC
-
-
Mashup Score: 23COVID-19 Guideline, Part 1: Treatment and Management - 2 year(s) ago
IDSA has developed living, frequently updated evidence-based guidelines to support patients, clinicians and other health-care professionals in their decisions about treatment and management of patients with COVID-19 infection. Summarized here are the recommendations with comments related to the clinical practice guideline for the treatment and management of COVID-19.
Source: www.idsociety.orgCategories: Infectious Disease, Latest HeadlinesTweet-
For evidence appraisal & rationale, please visit https://t.co/YRCxtdzoZT.
-
Update Alert: Revised recommendation on the use of #convalescentplasma in ambulatory patients w/ COVID-19 at high risk of progression to severe disease w/ no other treatment options. 📄: https://t.co/YRCxtdilXT #COVID19Guidelines @JGPharmD @adarsh_bhimraj @RMKGandhi @ShohamTxID https://t.co/KpXnywH362
-
-
Mashup Score: 3
Transfusions of blood plasma donated by people who have already recovered from infection with the pandemic virus may help other patients hospitalized with COVID-19, a new international study shows.
Source: medicalxpress.comCategories: General Medicine News, Latest HeadlinesTweet-
New study validates benefits of #convalescentplasma for some #COVID-19 patients @nyulangone @jamanetworkopen @JAMAInternalMed https://t.co/Vq4oWl3bKs
-
-
Mashup Score: 21Plasma Donation - 2 year(s) ago
Make your blood donation go further by donating blood plasma. A single AB Elite donation can provide up to three units of plasma to patients in need, giving you the power to make an even greater impact.
Source: www.redcrossblood.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
If you have had #COVID19, esp if #vaxxed, & you are out of isolation, please donate #convalescentplasma. It can help ppl w/ #Omicron who are #immunocompromised or #immunosuppressed. If not, give 🩸. Supply critically low. #GetVaxxed #GetBoosted #MedTwitter https://t.co/QGaF9JhGBT
-
-
Mashup Score: 1Randomized Controlled Trial of Early Outpatient COVID-19 Treatment with High-Titer Convalescent Plasma - 2 year(s) ago
BACKGROUND The efficacy of polyclonal high titer convalescent plasma to prevent serious complications of COVID-19 in outpatients with recent onset of illness is uncertain. METHODS This multicenter, double-blind randomized controlled trial compared the efficacy and safety of SARS-CoV-2 high titer convalescent plasma to placebo control plasma in symptomatic adults ≥18 years positive for SARS-CoV-2…
Source: medRxivCategories: Hem/Oncs, Latest HeadlinesTweet-
📣#Preprint #COVID19 #ConvalescentPlasma 📌RCT (N=1.2K) 📌Outpatients age 18+ 📌High-titer CCP (>1:320) vs placebo plasma w/in 9d of symptoms 📌Primary endpt: Hosp/death by d28 📌CCP 🏆: 54% ⬇️, driven by non-ICU hospitalizations (NNT=29); HR 0.46, p<.01 https://t.co/bcGwLFf2CL https://t.co/3LEa8ogeGw
-
-
Mashup Score: 0Convalescent plasma fails to reduce respiratory failure, death in COVID-19 pneumonia - 2 year(s) ago
Convalescent plasma failed to reduce progression to severe respiratory failure or death within 30 days in patients with moderate to severe COVID-19 pneumonia, according to a new study published in JAMA Network Open.“Randomized clinical trials already published or available as preprint versions have not shown a clear benefit of [convalescent plasma] in reducing the risk of disease
Source: www.healio.comCategories: Latest Headlines, PulmonologyTweet-
In the TSUNAMI trial, #convalescentplasma failed to reduce progression to respiratory failure or death at 30 days in patients with #COVID19 #pneumonia @JAMANetworkOpen @InfectDisNews https://t.co/lnmPA68PVk
-
-
Mashup Score: 0
Results from the CONTAIN COVID-19 trial showed that convalescent plasma did not meet prespecified efficacy endpoints in patients hospitalized with COVID-19. However, exploratory subgroup analyses of the trial revealed that high-titer COVID-19 convalescent plasma (CCP) may have benefited patients before remdesivir and corticosteroids were available, indicating “a heterogenous treatment
Source: www.healio.comCategories: General Medicine News, Latest HeadlinesTweet-
#Convalescentplasma may have benefited patients in early days of #COVID19pandemic, researchers wrote https://t.co/Zxq5hSYkl3
-
ICYMI, #IDSAGuidelines now recommend AGAINST routine use of #convalescentplasma among immunocompetent patients & suggests against use among #immunocompromised patients hospitalized with COVID-19. https://t.co/XdWcNHa1m7 https://t.co/TAqM8KQoKa